by last | May 4, 2021 | 2021, Press Releases, Scientific
Study shows impressive tumor uptake of OncoFAP with unprecedented selectivity against healthy organs. OncoFAP-based molecules are currently being developed for the imaging and therapy of cancer. Philogen announces participation to the 10th World Congress of Melanoma...by last | Apr 13, 2021 | 2021, Press Releases
Study shows impressive tumor uptake of OncoFAP with unprecedented selectivity against healthy organs OncoFAP-based molecules are currently being developed for the imaging and therapy of cancer PRESS RELEASE – PNASby last | Apr 12, 2021 | 2021, Press Releases
Study shows the generation of a high-quality stereo- and regiodefined DNA-encoded chemical library. Identified ligands against tumor-associated antigens can serve as vehicles for pharmacodelivery applications. PRESS RELEASE – PUBLICATIONby last | Mar 8, 2021 | 2021, Press Releases
Philogen will be attending the digital World ADC Europe Conference from March 8 to 11, 2021. Dr. Samuele Cazzamalli – Head of Small Molecule Therapeutics – will give a Plenary Lecture on: “Small Molecule-Drug Conjugates: Getting Small to Enhance...by last | Feb 22, 2021 | 2021, Press Releases
Link to Paperby last | Jan 13, 2021 | 2021, Press Releases, Scientific
NidlegyTMwas found to be well-tolerated and 149 out of the anticipated 214 patients have been safely treated. Data Safety Monitoring Board recommends to continue the study as planned. PRESS RELEASE – 13/01/2021
Recent Comments